Skyhawk Therapeutics is a privately held biotechnology company headquartered in Waltham, Massachusetts, that develops innovative approaches to treating various diseases through strategic international partnerships.
Subscribe to see Skyhawk Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Skyhawk Therapeutics is a biotechnology company headquartered in United States. Xcout tracks 3 named people at Skyhawk Therapeutics, including Bill Haney (Co-Founder, Chief Executive Officer, & Chairman). Xcout recorded 3 job postings from Skyhawk Therapeutics in the last 90 days.
Xcout recorded 3 job postings from Skyhawk Therapeutics in the last 90 days, from a hiring record Xcout has kept since October 2026.
The weekly hiring trend, the roles and locations behind it — see Skyhawk Therapeutics's hiring signals →
A few of Skyhawk Therapeutics's closest competitors — see the full list of competitors and alternatives →
Orionis Biosciences is a biotechnology research company with its US headquarters located in Waltham, Massachusetts, specializing in innovative life sciences and drug discovery services.
Falcon Therapeutics, Inc., in association with Skyhawk Therapeutics, conducts global clinical trials for Huntington's disease. The company serves patients with Huntington's disease by evaluating the small molecule splicing modifier SKY-0515 to lower mutant huntingtin protein levels and slow disease progression.
DynamiCure Biotechnology is a life sciences company applying innovative approaches to drug discovery from its facilities in Waltham, Massachusetts.
Apogee Therapeutics is a biotechnology company focused on the development of therapies for inflammatory and immunology diseases. The company is headquartered in Waltham, Massachusetts.
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Skyhawk Therapeutics? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.